GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lasa Supergenerics Ltd (BOM:540702) » Definitions » Price-to-Owner-Earnings

Lasa Supergenerics (BOM:540702) Price-to-Owner-Earnings : (As of May. 31, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Lasa Supergenerics Price-to-Owner-Earnings?

As of today (2025-05-31), Lasa Supergenerics's share price is ₹14.80. Lasa Supergenerics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Lasa Supergenerics's Price-to-Owner-Earnings or its related term are showing as below:

During the past 9 years, the highest Price-to-Owner-Earnings of Lasa Supergenerics was 68.30. The lowest was 9.57. And the median was 24.80.


BOM:540702's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.25
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-31), Lasa Supergenerics's share price is ₹14.80. Lasa Supergenerics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-3.15. Therefore, Lasa Supergenerics's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-31), Lasa Supergenerics's share price is ₹14.80. Lasa Supergenerics's EPS without NRI for the trailing twelve months (TTM) ended in was ₹-2.99. Therefore, Lasa Supergenerics's PE Ratio without NRI for today is At Loss.

During the past 9 years, Lasa Supergenerics's highest PE Ratio without NRI was 70.02. The lowest was 0.00. And the median was 19.33.


Lasa Supergenerics Price-to-Owner-Earnings Historical Data

The historical data trend for Lasa Supergenerics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lasa Supergenerics Price-to-Owner-Earnings Chart

Lasa Supergenerics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - 9.53 48.77 - -

Lasa Supergenerics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lasa Supergenerics's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Lasa Supergenerics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lasa Supergenerics's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lasa Supergenerics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Lasa Supergenerics's Price-to-Owner-Earnings falls into.


;
;

Lasa Supergenerics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Lasa Supergenerics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=14.80/-0.37
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lasa Supergenerics  (BOM:540702) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Lasa Supergenerics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Lasa Supergenerics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Lasa Supergenerics Business Description

Traded in Other Exchanges
Address
Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, Pharmaceuticals, drugs, and others. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products.

Lasa Supergenerics Headlines

No Headlines